← FDA DRUG APPROVALS

FDA ANDA · ANDA075787

FLUOXETINE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA075787
TYPE
ANDA
ORIGINAL APPROVAL
2002-01-29
LATEST ACTION
2007-06-29
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

FLUOXETINEDiscontinued
FLUOXETINE HYDROCHLORIDE EQ 20MG BASE · CAPSULE · ORAL
FLUOXETINEDiscontinued
FLUOXETINE HYDROCHLORIDE EQ 10MG BASE · CAPSULE · ORAL

Approval history

2007-06-29Labeling · Supplement 11AP
2007-06-29Labeling · Supplement 12AP
2005-06-30Labeling · Supplement 4AP
2002-01-29Original — Other Important Information from FDA ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →